QUOTE AND NEWS
newratings.com  Oct 29  Comment 
NEW YORK, October 29 (newratings.com) - Analysts at ThinkEquity Partners upgrade ViroPharma (ticker: VPHM) from "source of funds" to "buy." [more]
StreetInsider.com  Oct 28  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/ViroPharma+%28VPHM%29+Posts+Q3+EPS+of+%240.26%2C+In-Line+with+Estimates/5050948.html for the full story.
PR Newswire  Oct 15  Comment 
EXTON, Pa., Oct. 15 /PRNewswire-FirstCall/ -- ViroPharma Incorporated's (Nasdaq: VPHM) third quarter financial results for 2009 are expected to be released on Wednesday, October 28, 2009 before the open of the U.S. financial markets. The company will
Wall Street Journal  Oct 13  Comment 
Small-capitalization stocks ended near flat Monday as the energy sector tacked on some big gains thanks to a jump in oil prices, but financials and consumer staples slid.
Market Intelligence Center  Oct 12  Comment 
ViroPharma (VPHM) could be on the move today and is now at $9.50, down $0.30 (-3.06%) on volume of 1,085,972 shares traded. Over the last 52 weeks the stock has ranged from a low of $3.79 to a high of $14.55. ViroPharma stock has been showing...
Market Intelligence Center  Sep 28  Comment 
ViroPharma (VPHM) was upgraded today by analysts at Oppenheimer and the stock is now at $9.93, up $0.98 (10.95%) on volume of 2,212,671 shares traded. The brokerage lifted VPHM to Outperform from Perform. Over the last 52 weeks the stock has...
PR Newswire  Sep 15  Comment 
EXTON, Pa., Sept. 15 /PRNewswire-FirstCall/ -- ViroPharma Incorporated (Nasdaq: VPHM) today announced that the company will be presenting at several upcoming healthcare investment conferences. Vincent Milano, president and chief executive officer of
Suggest a News Source
Topic
Top news source/blog that we're missing
Why do you recommend this news source?
Close 
Thanks for your suggestion!
 


 
VPHM AT A GLANCE
 
 
 
 
 
 
 
 




References

Wikinvest © 2006, 2007, 2008, 2009. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki